Therapeutic Use of Genetic Testing in Advanced Prostate Cancer

Alan H. Bryce, MD, argues that the urologic community should expand genetic testing in prostate cancer patients in order to better recognize aberrations in patients' genes. Also, this would be a step closer to gaining FDA approved biomarkers for prostate cancer.